Sniff your way to recovery? nasal spray tested for COVID-19
NCT ID NCT05541510
Summary
This study tested a nasal spray called AD17002 to see if it could help adults with mild to moderate COVID-19 get better faster. About 180 participants were randomly assigned to receive either a placebo or one of two doses of the spray, in addition to standard care. The main goals were to measure how quickly symptoms improved and how safe the treatment was, but the trial was stopped early.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COVID - 19 are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
RSA UGM
Yogyakarta, Special Region of Yogyakarta, 55281, Indonesia
-
RSDC Wisma Atlit
Kota Jkt Utara, DKI Jakarta, 14360, Indonesia
-
RSPI Sulianti Saroso
Kota Jkt Utara, DKI Jakarta, 14340, Indonesia
Conditions
Explore the condition pages connected to this study.